In the study by Yang et al. [55], the authors identified a crucial role for the centrosomal protein TACC2 in modulating chemokine-mediated immune responses in soft tissue sarcoma (STS), together with a key role of CCL3 in the anti-tumor response. This evidence concerns the gene CCL3 and neoplasm.